Titan America SA Common Shares (TTAM)
14.85
+0.48 (3.34%)
NYSE · Last Trade: Nov 22nd, 4:19 AM EST

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest opening, just slightly higher than its initial pricing.
Via Talk Markets · February 9, 2025
